Dr. Arshad M. Khanani, MD, MA, FASRS, is a globally acclaimed retina specialist known for his innovative work in advancing treatments for retinal diseases. He serves as the Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates, as well as a Clinical Professor at the University of Nevada, Reno School of Medicine.

A leader in clinical research, Dr. Khanani has served as a principal investigator over 130 clinical trials, including first-in-human studies focused on sustained drug delivery and gene therapy. His efforts have contributed significantly to the development of breakthrough therapies for age-related macular degeneration, diabetic retinopathy, and geographic atrophy.

Dr. Khanani has published more than 100 peer-reviewed articles and is the founder of Clinical Trials at the Summit, a meeting designed to promote collaboration and innovation in retina research. He is an esteemed member of both the Macula Society and the Retina Society and has been honored with numerous prestigious awards. These include the Macula Society Lawrence J. Singerman Medal (2025), the American Academy of Ophthalmology Achievement Award (2024), the ASRS Presidents’ Young Investigator Award (2021), and the ASRS Presidential Award (2024). In recognition of his impact, he was named among the Top 10 ophthalmology researchers in the world by The Ophthalmologist Power List 2025.

“My goal is to bring hope to those at risk of losing their vision by advancing therapies that protect and restore sight,” says Dr. Khanani. “I truly believe that no one should lose vision from a disease that we have the power to treat.”